Aureon Laboratories Named 2010 Recipient of Yonkers Hidden Treasure Award
5/5/2010 8:27:42 AM
More...
|
Aureon Laboratories Raises $18 Million
3/19/2010 7:31:43 AM
More...
|
Aureon Laboratories Announces Name Change for Existing Post-Surgical Prostate Cancer Recurrence Test
3/5/2010 8:16:22 AM
More...
|
Aureon Laboratories Announces Appointment of New Executive Vice President and CFO
1/14/2010 9:19:10 AM
More...
|
Aureon Laboratories Announces Hiring of Vice President of Sales
10/13/2009 8:17:20 AM
More...
|
Aureon Laboratories Announces Appointment of New CEO
8/25/2009 8:52:29 AM
More...
|
M. D. Anderson Cancer Center and Aureon Laboratories to Evaluate Biomarkers Associated with Non-Small Cell Lung Cancer
6/10/2008 8:45:53 AM
More...
|
Aureon Laboratories Introduces Prostate Px(R)+, First Biopsy-Based Test to Predict Prostate Cancer Disease Progression and Recurrence
5/19/2008 8:54:12 AM
More...
|
Aureon Laboratories to Collaborate with Pfizer Inc. (PFE) to Establish Quantitative Biometrics for Assessing Therapeutic Response of Prostate Cancer Patients Treated with Hormone Therapy
1/22/2008 9:17:34 AM
More...
|
Aureon Laboratories to Collaborate with University of California, San Francisco (UCSF) on Research Study to Construct Predictive Models for GM-CSF Treatment Response in Patients with Prostate Cancer
10/15/2007 11:31:50 AM
More...
|
|